Andrzej Jakubowiak to Intention to Treat Analysis
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Intention to Treat Analysis.
Connection Strength
0.071
-
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. N Engl J Med. 2018 02 08; 378(6):518-528.
Score: 0.039
-
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma. N Engl J Med. 2015 Jan 08; 372(2):142-52.
Score: 0.032